SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-24-063603
Filing Date
2024-05-21
Accepted
2024-05-21 09:02:32
Documents
8
Period of Report
2024-06-21

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2411645-2_def14a.htm DEF 14A 866328
2 GRAPHIC lg_jaguarhealth-4c.jpg GRAPHIC 33425
3 GRAPHIC sg_lisaaconte-bw.jpg GRAPHIC 12231
4 GRAPHIC bc_tsr-bw.jpg GRAPHIC 48582
5 GRAPHIC bc_netloss-bw.jpg GRAPHIC 45827
6 GRAPHIC px_24jaguarproxy1pg01-bw.jpg GRAPHIC 220803
7 GRAPHIC px_24jaguarproxy1pg02-bw.jpg GRAPHIC 323256
8 GRAPHIC px_24jaguarproxy1pg03-bw.jpg GRAPHIC 407601
  Complete submission text file 0001104659-24-063603.txt   2306552
Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36714 | Film No.: 24967047
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)